Intranasal immunization with recombinant gD2 reduces disease severity and mortality following genital challenge with herpes simplex virus type 2 in guinea pigs-Reference-Cited by-同舟云学术

Intranasal immunization with recombinant gD2 reduces disease severity and mortality following genital challenge with herpes simplex virus type 2 in guinea pigs

Published:1999-05 Issue:18 Volume:17 Page:2229-2236
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

O'Hagan Derek,Goldbeck Cheryl,Ugozzoli Mildred,Ott Gary,Burke Rae Lyn

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference30 articles.

1. Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world;Nahmias;Scand. J. Infect. Dis. Suppl.,1990

2. Genital herpes simplex infections: current concepts in diagnosis, therapy and prevention;Corey;Ann. Int. Med.,1983

3. A seroepidemiologic survey of the presence of herpes simplex virus type 2 infection in the United States;Johnson;N. Engl. J. Med.,1989

4. Herpes simplex virus glycoprotein D mediated interference with herpes simplex virus infections;Johnson;J. Virol.,1989

5. The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine;Sanchez-Pescador;J. Immunol.,1988

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nasal Immunization Confers High Avidity Neutralizing Antibody Response and Immunity to Primary and Recurrent Genital Herpes in Guinea Pigs;Frontiers in Immunology;2016-12-26

2. Herpes Simplex Virus 1 and 2 Vaccine Design: What can we Learn from the Past?;Herpesviridae;2016-09-07

3. Adjuvants: Classification,Modus Operandi, and Licensing;Journal of Immunology Research;2016

4. Prospects and perspectives for development of a vaccine against herpes simplex virus infections;Expert Review of Vaccines;2014-07-31

5. HSV-2 vaccine: Current state and insights into development of a vaccine that targets genital mucosal protection;Microbial Pathogenesis;2013-05